CYDY Stock Analysis: Biotech stock CytoDyn Inc. poised for potential $100B+ valuation on FDA approval. Recent shareholder meeting highlights company's growth prospects. Chairman's message signals exciting times ahead for investors. Stay tuned for updates on this promising stock.